Study Explores Use Of PROCRIT(R) (Epoetin Alfa) Once Every Two Weeks As Initiation Treatment For Chemotherapy-Related Anemia

... New study results presented todaysuggest that 80,000 units of PROCRIT(R) (Epoetin alfa) administered onceevery two weeks demonstrated comparable changes in hemoglobin (red bloodcell) levels and safety in treating chemotherapy-related anemia in patientswith non- myeloid malignancies compared to 40,000 units of PROCRIT onceweekly, the current recommended dosage. [click link for full article] ...